ABG Analytics logo
 

Merck & Co (NYSE: MRK)

DRUGS - Drug Manufacturers - Major
Sector: Health Care
Stock price data as of 02/16/2024
Closing price: 127.79
Support price level: $113.97
Resistance price level: N/A
Relative strength index (14-day RSI) 75.1
Beta 0.27
  • MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.

  • The price of this low-beta stock is expected to increase by 0.27% for every 1% increase in the S&P-500.

  • Volatility is forecast to fall over the next month.

  • With RSI > 70, MRK is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$100.18 $127.79 100.0%
200 day 50 day 20 day 10 day
$109.90 $116.25 $123.96 $126.35
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
23.0% 17.8% 18.5% 20.6%
There is an estimated 5% probability that the stock price of Merck & Co will fall by more than:
  • 5.0% in the next week.

  • 11.6% in the next month.

  • 36.8% in the next year.